Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Eiko LifesciencesBOM:540204 +1.59%70 Days Payable is 76.09 as of Mar. 2026, which is 144% above its 10-year median of 31.17. GuruFocus rates BOM:540204 with a GF Score™ of 70/100 and a GF Value™ of ₹79.20 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 1,553 Chemicals companies, Eiko Lifesciences ranks worse than 58.6% on this metric.
The historical rank and industry rank for Eiko Lifesciences's Days Payable or its related term are showing as below:
BOM:540204'
s Days Payable Range Over the Past 10 Years
Min: 17.27 Med: 31.17 Max: 3641.16
Current: 51.83
During the past 13 years, Eiko Lifesciences's highest Days Payable was 3641.16. The lowest was 17.27. And the median was 31.17.
BOM:540204's Days Payable is ranked worse than 58.6% of 1553
companies
in the Chemicals industry
Industry Median: 59.87
vs BOM:540204: 51.83
Eiko Lifesciences's Days Payable
increased
from Mar. 2025 (33.18) to Mar. 2026 (76.09).
It may suggest that Eiko Lifesciencesdelayed paying its suppliers.
Eiko Lifesciences Days Payable Related Terms
Eiko Lifesciences Days Payable Historical Data
* Premium members only.
The historical data trend for Eiko Lifesciences's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:540204 vs LIN, SHW, ECL: Days Payable Comparison
For the Specialty Chemicals subindustry, Eiko Lifesciences's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eiko Lifesciences Days Payable vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Eiko Lifesciences's Days Payable distribution charts can be found below:
* The bar in red indicates where Eiko Lifesciences's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Eiko Lifesciences's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eiko Lifesciences (BOM:540204) has a Days Payable of 76.09 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Eiko Lifesciences and its competitors. This is 144% above median its historical median of 31.17. Over the past decade, Eiko Lifesciences' Days Payable has ranged from 17.27 to 3,641.16. According to the industry distribution chart, Eiko Lifesciences ranks #910 out of 1553 companies in the Chemicals industry, placing it in the top 58.6%.
Is Eiko Lifesciences' Days Payable too high?
Eiko Lifesciences' current Days Payable of 76.09 is 144% above median its 10-year median of 31.17. Over the past 10 years, this metric has ranged from a low of 17.27 to a high of 3,641.16. The Chemicals industry median Days Payable is 59.87. Eiko Lifesciences' value of 76.09 is 27.1% above this industry median. Based on the distribution chart, Eiko Lifesciences ranks #910 out of 1553 companies in the Chemicals industry, which is below the industry midpoint. Overall, Eiko Lifesciences has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Eiko Lifesciences' Days Payable compare to LIN and SHW?
According to the Chemicals industry distribution chart, Eiko Lifesciences ranks #910 out of 1553 companies for Days Payable. This places Eiko Lifesciences in the lower half of its industry. The industry median Days Payable is 59.87. Eiko Lifesciences' value of 76.09 is 27.1% above this benchmark. Historically, Eiko Lifesciences' own Days Payable has ranged from 17.27 to 3,641.16 over the past decade. While the company's 10-year median is 31.17 vs. the industry median of 59.87, Eiko Lifesciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Chemicals company?
The median Days Payable among Chemicals companies is 59.87, based on 1,553 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eiko Lifesciences's current Days Payable of 76.09 is 27.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Eiko Lifesciences and its competitors. For the Chemicals industry, the median Days Payable is 59.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eiko Lifesciences's current Days Payable is 76.09, which is 144% above median its own 10-year median of 31.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eiko Lifesciences stock overvalued right now?
Based on GuruFocus' analysis, Eiko Lifesciences (BOM:540204) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹79.20, compared to a current price of ₹49.71 — trading 37.2% below its estimated fair value. The current Days Payable is 76.09, which is 144% above median its 10-year median of 31.17 and 27.1% above the Chemicals industry median of 59.87. Eiko Lifesciences' overall GF Score™ is 70/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Eiko Lifesciences (BOM:540204), the current Days Payable is 76.09 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eiko Lifesciences (BOM:540204) Overvalued in 2026?
Based on GuruFocus' analysis, Eiko Lifesciences stock appears to be undervalued.
The current stock price of ₹49.71 is trading 37.2% below its estimated GF Value™ of ₹79.20.
GuruFocus considers Eiko Lifesciences to be Significantly Undervalued.
Key valuation signals for BOM:540204:
Days Payable: 76.09 (144% above median its 10-year median of 31.17)
GF Value™: ₹79.20 vs. price of ₹49.71 (37.2% below fair value)
Industry Position: 27.1% above the Chemicals median (#910 of 1553)
No single metric tells the full story. See the BOM:540204 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eiko Lifesciences Ltd is a manufacturer, supplier, and exporter of specialty chemicals, fine chemicals, and pharma intermediates.. The company's segment includes Agrochemicals, Oleo Chemicals, Pharmaceuticals, Food Additives, clinical research, development, and Logistics. Geographically, the company generates the majority of its revenue from the Domestic market.
70GF Score
Get the complete analysis for BOM:540204
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:540204 has been successfully added to your 
